ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,064.20
0.91%
Dow Jones
38,225.66
0.85%
US Dollar vs MXN
16.9827
0.06%
Brent Oil
83.775
0.17%
Bitcoin
59,573.14
0.76%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Arcellx Inc (ACLX)

  7. Arcellx Inc (ACLX) Noticias

ACLX Arcellx Inc

53.29
1.11 (2.13%)
02 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Arcellx Inc ACLX NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
1.11 2.13% 53.29 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
52.46 51.32 54.05 53.29 52.18
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
04/4/202415:00BWArcellx to Participate in the 23rd Annual Needham Virtual..
20/3/202415:00BWArcellx to Participate at the H.C. Wainwright 2nd Annual..
07/3/202417:23EDGAR2Form 144 - Report of proposed sale of securities
29/2/202415:00PRNUSArcellx to Participate at the TD Cowen 44th Annual Health..
28/2/202415:02EDGAR2Form 8-K - Current report
28/2/202415:00PRNUSArcellx Provides Fourth Quarter and Year-End 2023 Financial..
14/2/202416:57EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12/2/202418:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/2/202415:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/2/202420:41EDGAR2Form 144 - Report of proposed sale of securities
31/1/202415:19EDGAR2Form 8-K - Current report
08/1/202415:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202415:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202419:24EDGAR2Form 144 - Report of proposed sale of securities
04/1/202419:23EDGAR2Form 144 - Report of proposed sale of securities
04/1/202418:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202418:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202415:22EDGAR2Form S-8 - Securities to be offered to employees in employee..
28/12/202317:06EDGAR2Form 144 - Report of proposed sale of securities
28/12/202315:47EDGAR2Form 8-K - Current report
19/12/202315:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202315:33EDGAR2Form 144 - Report of proposed sale of securities
18/12/202315:16EDGAR2Form SC 13D/A - General statement of acquisition of..
14/12/202316:52EDGAR2Form 144 - Report of proposed sale of securities
12/12/202306:37EDGAR2Form 8-K - Current report
08/12/202316:16EDGAR2Form 8-K - Current report
08/12/202315:00PRNUSArcellx Announces Continued Robust Long-Term Responses from..
15/11/202307:30DJNArcellx Shares Rise Premarket on Expanded Gilead..
15/11/202305:58DJNGilead Invests Further in Arcellx, Extends Collaboration
15/11/202305:16EDGAR2Form 8-K - Current report
15/11/202305:00BWKite and Arcellx Announce Expansion in Strategic Partnership
13/11/202315:05EDGAR2Form 8-K - Current report
13/11/202315:00PRNUSArcellx Provides Third Quarter 2023 Financial Results and..
02/11/202308:13EDGAR2Form 8-K - Current report
02/11/202308:00PRNUSArcellx Announces Oral Presentation for Its CART-ddBCMA..
26/10/202315:00PRNUSArcellx to Participate in Two Upcoming Investor Conferences
14/8/202315:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202315:06EDGAR2Form 8-K - Current report
14/8/202315:00PRNUSArcellx Announces Partial Clinical Hold Lifted on iMMagine-1..
07/8/202315:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/8/202315:14EDGAR2Form 144 - Report of proposed sale of securities
21/7/202315:44EDGAR2Form SC 13G - Statement of acquisition of beneficial..
05/7/202319:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/7/202312:27EDGAR2Form 144 - Report of proposed sale of securities
20/6/202305:57DJNArcellx Shares Drop After Patient Death Draws Clinical Hold..
19/6/202318:46PRNUSArcellx Announces Clinical Hold for its iMMagine-1 Phase 2..
08/5/202315:00PRNUSArcellx Provides First Quarter Financial Results

Su Consulta Reciente

NASDAQ
ACLX
Arcellx
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados